Volume 6 Issue 3 - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Drug Discovery, Development & Delivery V6I3

Device Design is Driving Innovation

Devices are playing an increasingly important role in medicine. Medical devices offer innovative examination and treatment options and drug delivery devices permit p...

1 October 2014 Drug Discovery, Development & Delivery V6I3 | Editorial Archive | Volume 6 Issue 3

Continue Reading →

Drug Discovery, Development & Delivery V6I3

The Respiratory Drug Delivery Asia 2014 – A Preview

The Respiratory Drug Delivery (RDD®) Asia 2014 scientific conference will welcome pulmonary and nasal drug delivery experts from all over the world to Goa, India fro...

1 October 2014 Drug Discovery, Development & Delivery V6I3 | Editorial Archive | Volume 6 Issue 3

Continue Reading →

Editorial Archive

Get Ownership of your IP Right; Otherwise it can Turn into a Nightmare!

When filing a patent application, there are lots of things to consider. Most of the attention is directed towards getting the disclosure of the invention right and e...

1 October 2014 Editorial Archive | Regulatory & Marketplace V6I3 | Volume 6 Issue 3

Continue Reading →

Editorial Archive

Global Tracking Regulations Present Challenges and Benefits

Lars Hoejberg of NNIT looks into serialisation, the foundation of any tracking system. Drug makers are facing an ever-increasing challenge as more countries implemen...

1 October 2014 Editorial Archive | Regulatory & Marketplace V6I3 | Volume 6 Issue 3

Continue Reading →

Editorial Archive

Funding Options for R&D in the Life Sciences Sector

Typically, funding for R&D and business growth has been hard to secure over previous years due to the financial crisis. However, now that the financial uncertain...

1 October 2014 Editorial Archive | Regulatory & Marketplace V6I3 | Volume 6 Issue 3

Continue Reading →

Editorial Archive

The 3E Principle: Key Considerations for Selecting and Outsourcing to a Vendor

Influenced by forces such as macroeconomics, politics, regulations, population growth and aging, there has been a major shift in the way biopharmaceutical companies ...

1 October 2014 Editorial Archive | Regulatory & Marketplace V6I3 | Volume 6 Issue 3

Continue Reading →

Editorial Archive

The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists

Pharmaceutical companies have widely adopted strategies to outsource elements of their business operations, as part of an ongoing drive to deliver a more flexible mo...

1 October 2014 Editorial Archive | Regulatory & Marketplace V6I3 | Volume 6 Issue 3

Continue Reading →

Editorial Archive

Regulatory Scenario of Herbal Medicines: A Global Review

In the last few decades there has been exponential growth in the field of herbal medicine and regulation of herbal medicines has become key to ensuring the safety, e...

1 October 2014 Editorial Archive | Regulatory & Marketplace V6I3 | Volume 6 Issue 3

Continue Reading →

Editorial Archive

Accelerating the Development of Generic Pharmaceuticals: Developing an Analytical Toolkit Suitable for De-Formulating Complex Reference Products

In its report “Critical Path Opportunities for Generic Drugs”, the FDA emphasises the need for advances in the field of analytical sciences in order to accelerate th...

1 October 2014 Editorial Archive | Manufacturing V6I3 | Volume 6 Issue 3

Continue Reading →